Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06382493 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Tegoprazan-containing Sequential for H. Pylori

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion dates: Dec 12, 2024 to Dec 12, 2026v3
  2. Interventions: Tegoprazan-containing sequential H. pylori eradication therapy (Drug) to Esomeprazole-containing sequential H. pylori eradication therapy (Drug), Tegoprazan-containing sequential H. pylori eradication therapy…
    • Eligibility criteria expanded, about 9 words
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
As H. pylori eradication, the investigators prepared a randomized controlled clinical trial whether tegoprazan-containing 10-day sequential treatment was effective compared to conventional PPI-containing 10-day sequential eradication therapy
Trial Details
NCT Number NCT06382493
Lead Sponsor Seoul National University Bundang Hospital
Conditions
(from sponsor)		 Helicobacter Pylori Infection
Enrollment 400 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov